Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

GSK

GSK Plc ADR

Oct 31 • 04:00PM ET

46.86

-0.08 -0.17 %

Healthcare • Drug Manufacturers - General • United Kingdom • NYSE

Peers: JNJ PFE MRK BMY LLY NVS AZN ABBV SNY GILD

| Held by: PPH AVDE FVD FENI RODM DFAX AVIV BINV FFLC PLDR

Scroll to Statements

Index	-	P/E	13.36	EPS (ttm)	3.51	Insider Own	0.00%	Shs Outstand	2.01B	Perf Week	8.37%
Market Cap	94.20B	Forward P/E	9.67	EPS next Y	4.84	Insider Trans	-	Shs Float	2.01B	Perf Month	7.26%
Enterprise Value	113.11B	PEG	1.38	EPS next Q	0.63	Inst Own	19.16%	Short Float	0.66%	Perf Quarter	24.36%
Income	7.22B	P/S	2.24	EPS this Y	10.59%	Inst Trans	-0.13%	Short Ratio	2.74	Perf Half Y	19.94%
Sales	42.06B	P/B	4.34	EPS next Y	9.85%	ROA	9.00%	Short Interest	13.33M	Perf YTD	38.56%
Book/sh	10.80	P/C	21.16	EPS next 5Y	9.69%	ROE	35.62%	52W High	47.16 -0.64%	Perf Year	22.77%
Cash/sh	2.21	P/FCF	11.77	EPS past 3/5Y	-24.61% -11.63%	ROIC	17.27%	52W Low	31.72 47.75%	Perf 3Y	43.35%
Dividend Est.	1.73 (3.69%)	EV/EBITDA	7.78	Sales past 3/5Y	5.68% -1.42%	Gross Margin	72.45%	Volatility	2.24% 2.01%	Perf 5Y	30.70%
Dividend TTM	1.64 (3.50%)	EV/Sales	2.69	EPS Y/Y TTM	128.66%	Oper. Margin	23.49%	ATR (14)	1.18	Perf 10Y	10.88%
Dividend Ex-Date	Nov 14, 2025	Quick Ratio	0.55	Sales Y/Y TTM	5.97%	Profit Margin	17.16%	RSI (14)	67.85	Recom	2.83
Dividend Gr. 3/5Y	-16.94% -9.13%	Current Ratio	0.84	EPS Q/Q	3676.49%	SMA20	5.91%	Beta	0.51	Target Price	45.07
Payout	94.89%	Debt/Eq	1.10	Sales Q/Q	10.64%	SMA50	11.30%	Rel Volume	1.03	Prev Close	46.94
Employees	68629	LT Debt/Eq	0.92	Earnings	Oct 29 BMO	SMA200	20.41%	Avg Volume	4.86M	Price	46.86
IPO	Mar 28, 1980	Option/Short	Yes / Yes	EPS/Sales Surpr.	15.87% 2.56%	Trades		Volume	5,027,258	Change	-0.17%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-03-25	Downgrade	Berenberg	Buy → Hold
Apr-15-25	Initiated	Exane BNP Paribas	Neutral	$35.25
Feb-12-25	Initiated	Morgan Stanley	Equal-Weight
Nov-15-24	Downgrade	Deutsche Bank	Buy → Hold
Nov-12-24	Downgrade	Jefferies	Buy → Hold	$53 → $39.50
Oct-31-24	Downgrade	Guggenheim	Buy → Neutral
Jul-08-24	Downgrade	UBS	Buy → Neutral
May-30-24	Initiated	Goldman	Neutral	$47
Mar-04-24	Upgrade	Guggenheim	Neutral → Buy
Feb-13-24	Upgrade	Citigroup	Neutral → Buy
Jan-23-24	Initiated	Morgan Stanley	Equal-Weight	$44
Jan-16-24	Resumed	UBS	Buy
Jan-03-24	Upgrade	Jefferies	Hold → Buy	$48
Jul-14-23	Initiated	HSBC Securities	Reduce
Mar-17-23	Upgrade	Deutsche Bank	Hold → Buy
Feb-27-23	Resumed	Goldman	Buy
Jan-03-23	Downgrade	JP Morgan	Neutral → Underweight
Dec-05-22	Downgrade	BofA Securities	Neutral → Underperform
Nov-11-22	Downgrade	UBS	Neutral → Sell
Sep-15-22	Upgrade	Credit Suisse	Underperform → Neutral

Show Previous Ratings

Today 10:20AM	GILD Q3 Earnings and Sales Beat Estimates, HIV and Livdelzi Sales Grow (Zacks)
Oct-30-25 10:34AM	Analyst Report: GSK plc (Morningstar Research)
07:45AM	GSK Rises 7% After Raising 2025 Profit Forecast (GuruFocus.com)
Oct-29-25 09:32PM	Jefferies Bullish on GSK, Citing Growth Pipeline and Efficiency Prospects (Insider Monkey) +5.10%
04:12PM	GSK Jumps On Hiked 2025 Outlook, But CEO Remains 'Very Cautious' About Vaccines (Investor's Business Daily)
02:34PM	Loading…
02:34PM	GSK Stock Surges as CEO Exits on a High Note with Forecast Hike and Surprise Drug Win (GuruFocus.com)
02:31PM	GSK Lifts 2025 Outlook on Strong HIV and Cancer Drug Growth (GuruFocus.com)
11:48AM	GSK's Q3 Earnings & Sales Beat Estimates, Stock Up on Raised '25 View (Zacks)
08:58AM	GSK Jumps After Hiked 2025 Guidance Widely Outperforms Expectations (Investor's Business Daily)
08:58AM	Should You Buy, Hold, or Sell GILD Stock Ahead of Q3 Earnings? (Zacks)
07:24AM	GSK Lifts Guidance After Specialty Medicines Boost Sales (The Wall Street Journal)
07:05AM	GSK (GSK) Q3 Earnings and Revenues Beat Estimates (Zacks)
04:08AM	GSK Raises Guidance After Sales, Earnings Growth (The Wall Street Journal)
Oct-28-25 09:45AM	Here's Why GSK (GSK) is a Strong Growth Stock (Zacks)
Oct-24-25 04:12PM	GSK Crumbles As Blood Cancer Comeback Falls Unexpectedly Short (Investor's Business Daily) -5.05%
12:07PM	Loading…
12:07PM	A GSK Cancer Drug Is Making a Comeback. It's So-So News for the Stock. (Barrons.com)
Oct-23-25 08:11PM	Blenrep approved by US FDA for use in treatment of relapsed/refractory multiple myeloma (Business Wire)
10:00AM	Illumina (ILMN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
Oct-22-25 06:45PM	Top Analyst Reports for Oracle, Toyota & Morgan Stanley (Zacks)
10:00AM	GSK (GSK) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Oct-21-25 09:50AM	Here's Why GSK (GSK) is a Strong Momentum Stock (Zacks)
Oct-20-25 09:40AM	Here's Why GSK (GSK) is a Strong Value Stock (Zacks)
09:30AM	Will Positive Regulatory Updates Further Boost INCY Stock? (Zacks)
Oct-14-25 10:56AM	Will Livmarli Continue to Drive Mirum's Top Line in Q3 Earnings? (Zacks)
Oct-10-25 08:50AM	How to Find Strong Medical Stocks Slated for Positive Earnings Surprises (Zacks)
Oct-09-25 09:45AM	Why GSK (GSK) is a Top Growth Stock for the Long-Term (Zacks)
Oct-07-25 09:37AM	Gilead Resolves Patent Litigations for HIV Treatment Biktarvy (Zacks)
08:50AM	Why Investors Need to Take Advantage of These 2 Medical Stocks Now (Zacks)
Oct-03-25 12:10PM	Will Glaxo (GSK) Beat Estimates Again in Its Next Earnings Report? (Zacks)
Oct-02-25 09:40AM	Why GSK (GSK) is a Top Value Stock for the Long-Term (Zacks)
05:34PM	Loading…
Oct-01-25 05:34PM	GSK (GSK) Touches All-Time High on Potential Exemption From Trump Tariff (Insider Monkey) +5.44%
04:36PM	Why Drug Stocks Are Celebrating Trump's 100% Pharmaceutical Tariff (Investor's Business Daily)
12:37PM	GSK's $30B US Gamble Sends Pharma Stocks Soaring After Trump Pricing Deal (GuruFocus.com)
10:00AM	New Local Data in GSK and IQVIA's Vaccine Track Supports Smarter Public Health Action at the Community Level (Business Wire)
Sep-30-25 07:48PM	Analyst Report: GSK plc (Morningstar Research) +5.01%
Sep-29-25 04:25PM	GSK Leaps Into Buy Zone On Surprise Departure Of CEO Emma Walmsley (Investor's Business Daily)
11:18AM	GSK Will Replace CEO Walmsley With a Company Insider. The Stock Is Up. (Barrons.com)
10:11AM	GSK CEO Emma Walmsley to Step Down (The Wall Street Journal)
08:07AM	CoreWeave, AstraZeneca, GSK, BYD, Tesla: Trending Stocks (Yahoo Finance Video)
06:59AM	Stocks to Watch Monday: Carnival, GSK, Alibaba (The Wall Street Journal)
06:07AM	Premarket movers: Merus, GSK, Novo Nordisk (MarketWatch)
04:46AM	GSK turns to insider to be next CEO - and the stock rallies (MarketWatch)
02:47AM	GSK Chief Emma Walmsley to Step Down, Luke Miels Named Successor (The Wall Street Journal)
Sep-26-25 03:48PM	Analyst Report: GSK plc (Morningstar Research)
05:31AM	Stock Market Today: Dow, S&P 500 and Nasdaq futures inch higher after three days of losses for stocks, with Fed's preferred inflation gauge ahead and fresh tariff announcements from Trump (MarketWatch)
05:30AM	U.S. stock futures indicate a losing streak could be over as PCE inflation looms and after fresh tariffs announced (MarketWatch)
Sep-24-25 10:16AM	Gilead Sciences Surges 26.5% YTD: Buy, Sell or Hold the Stock? (Zacks)
Sep-23-25 02:15PM	IONS' Rare Neurological Disease Drug Meets Late-Stage Study Goal (Zacks)
09:50AM	Why GSK (GSK) is a Top Momentum Stock for the Long-Term (Zacks)
Sep-22-25 06:40PM	GSK to submit label update for Leucovorin at FDA's request, does not intend to market it for autism (CNBC TV)
09:45AM	Here's Why GSK (GSK) is a Strong Growth Stock (Zacks)
Sep-18-25 11:38AM	RHHBY to Acquire 89bio for $3.5B, Add Late-Stage MASH Drug to Pipeline (Zacks)
02:10AM	GSK Commits $30 Billion To U.S. Expansion Over Five Years (GuruFocus.com)
Sep-17-25 03:52PM	GSK Commits $30B to Boost U.S. Pharma Expansion (GuruFocus.com)
03:23PM	GSK Just Dropped $30 Billion on America's Biotech Future--Here's What That Buys (GuruFocus.com)
11:56AM	GSK to Invest $30B in U.S. R&D and Manufacturing Over 5 Years (Zacks)
11:22AM	LLY's $5B Virginia Plant Plan: Will U.S. Manufacturing Shift Pay Off? (Zacks)
10:46AM	Trump's UK visit: US Big Tech to invest billions in UK's AI (Yahoo Finance Video)
07:30AM	Drugmakers' Pledges to Boost U.S. Manufacturing Pile Up (The Wall Street Journal)
05:35AM	Stocks to Watch Wednesday: Workday, StubHub, General Mills (The Wall Street Journal)
Sep-16-25 08:00PM	Drugmakers Have Pledged to Invest $350 Billion in U.S. After Tariff Threat (The Wall Street Journal)
07:01PM	GSK Says It Will Spend $30B on U.S. Manufacturing and R&D (Barrons.com)
11:15AM	Will GSK Be Able to Resolve Its Vaccine Challenges Anytime Soon? (Zacks)
09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Sep-12-25 08:14PM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
Sep-11-25 12:49PM	Kepler Capital Maintains a Hold Rating on GSK plc (GSK) (Insider Monkey)
11:30AM	Why Is Editas (EDIT) Down 16.9% Since Last Earnings Report? (Zacks)
Sep-06-25 12:58AM	TD Cowen Maintains a Hold Rating on GSK plc (GSK), Sets a PT of $45 (Insider Monkey)
Sep-03-25 11:30AM	BioMarin (BMRN) Down 4.6% Since Last Earnings Report: Can It Rebound? (Zacks)
10:47AM	IONS Hits 52-Week High on Tryngolza's Success in Lowering Triglyceride (Zacks)
Sep-02-25 05:33PM	Top Analyst Reports for NVIDIA, Chevron & Booking (Zacks)
09:48AM	GSK Adds Around $5B in a Month: Here's How to Play the Stock (Zacks)
Aug-26-25 09:40AM	GILD Wins Approval for Twice-Yearly HIV Prevention Shot in the EU (Zacks)
Aug-22-25 11:11AM	BMY vs GSK: Which Biopharma Bigwig Has Better Prospects for Now? (Zacks)
Aug-21-25 09:49AM	JAZZ Inks $1B Licensing Deal With Saniona for Epilepsy Drug (Zacks)
Aug-18-25 09:25AM	GILD Stock Up 7% Post Q2 Earnings: Should You Buy Now or Wait? (Zacks)
Aug-13-25 12:31PM	Theravance's Q2 Loss Narrower Than Expected, Revenues Rise Y/Y (Zacks)
Aug-11-25 04:19AM	GSK climbs after winning FDA priority review for oral gonorrhoea antibiotic (Investing.com)
Aug-08-25 09:23AM	GILD Stock Rises on Q2 Earnings and Sales Beat, '25 View Up (Zacks)
03:31AM	GSK to Receive $370 Million in U.S. Patent Litigation Settlement (The Wall Street Journal)
Aug-04-25 07:58AM	GILD Likely to Beat on Q2 Earnings: Buy, Sell or Hold the Stock? (Zacks)
Aug-01-25 07:46AM	Stocks Buckle Under Trump Tariffs; Amazon Slumps: Markets Wrap (Bloomberg)
07:21AM	Global Pharma Stocks Fall After Trump Demands Cuts in Drug Prices (The Wall Street Journal)
05:57AM	Stock Market Today: Stocks Fall on Trump's Tariff Blitz; Jobs Report Due (The Wall Street Journal)
Jul-31-25 04:16PM	What Trump's Big Pharma CEO letters mean for drug pricing power (Yahoo Finance Video)
09:22AM	Company News for Jul 31, 2025 (Zacks)
Jul-30-25 05:48PM	Analyst Report: GSK plc (Morningstar Research)
11:57AM	GSK CEO: Innovation is the secret to bringing down cost of overall healthcare (CNBC TV)
11:42AM	GSK Beats on Q2 Earnings & Sales, Stock Gains on '25 Outlook Raise (Zacks)
09:21AM	GSK Lifts Outlook As Specialty Medicines, Vaccines Fuel Growth (Benzinga)
07:05AM	GSK (GSK) Q2 Earnings and Revenues Beat Estimates (Zacks)
02:49AM	GSK Upbeat on Guidance After Specialty Medicines Boost Sales (The Wall Street Journal)
Jul-27-25 09:53PM	Hengrui Pharma and GSK enter agreements to develop up to 12 innovative medicines across Respiratory, Immunology & Inflammation and Oncology (PR Newswire)
Jul-24-25 02:59PM	Europes Pharma Stocks Look Cheap but Tariffs Cloud the Outlook (Barrons.com)
10:00AM	Analysts Estimate Bristol Myers Squibb (BMY) to Report a Decline in Earnings: What to Look Out for (Zacks)
09:00AM	GSK sponsors 2025 National Senior Games as part of Sideline RSV campaign to raise awareness of RSV in older adults (Business Wire)
Jul-23-25 10:00AM	GSK (GSK) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Jul-21-25 09:38AM	Viking Therapeutics Gears Up for Q2 Earnings: Here's What to Expect (Zacks)
Jul-19-25 11:12AM	Warren Buffett says this book changed his life forever. Here's the real key to long-term gains (Moneywise)
Jul-18-25 09:32PM	Stock Market News, July 18, 2025: Another Record for Nasdaq (The Wall Street Journal)

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

GSK

GSK Plc ADR

Upgrade your FINVIZ experience